Figure 2.

Outpatient Prescriptions of T2D medications in PCORnet (2012‐2017). The prevalence of outpatient prescriptions of T2D medications in the overall cohort of patients with T2D in PCORnet is presented. Data regarding outpatient T2D prescriptions were collected from the prescribing fields of the electronic medical record for each patient during the 90 days before and 90 days after t0 (the earliest date that the patient fulfilled any of the three computable phenotypes for the T2D cohort). T2D, Type 2 diabetes; PCORnet, National Patient‐Centered Clinical Research Network; DPP4, Dipeptidyl peptidase‐4 inhibitors; GLP‐1, glucagon‐like peptide‐1 receptor agonists (2.5%); TZD, thiazolidinediones; SGLT‐2, sodium‐glucose cotransporter‐2